Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 9, 2017Open Access

Targeting MicroRNAs in Cancer Gene Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

WJWeidan JiBSBin SunCSChangqing Su

Discussion

Loading...

Member takes

Overview

Review reveals therapeutic targeting strategies for microRNAs in tumor models, highlighting their utility as oncogenic drivers and clinical targets.

Key Points

  • To review the regulatory functions of microRNAs in tumorigenesis and evaluate evolving strategies and clinical applications for targeting them in cancer gene therapy.
  • Narrative review synthesizing evidence on microRNA expression profiles across diverse cancer cell lines and tumor tissues.
  • Evaluation of mechanistic roles of microRNAs in biological processes including proliferation, survival, motility, and tumor development.
  • MicroRNAs exhibit extensive dysregulation across multiple tumor types, causally functioning as either oncogenes or tumor suppressors throughout various stages of malignant progression.
  • Therapeutic strategies directed at modulating aberrant microRNAs provide viable molecular targets to suppress tumor growth and enhance the efficacy of cancer treatment regimens.

Cite This Study

Ji et al. (2017) studied this question.

synapsesocial.com/papers/6a8f83ad76d63252939f9fa4https://doi.org/10.20944/preprints201701.0046.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exploring Novel Therapeutic Breakthroughs for Cancers: Potential Roles of miRNAs2024
  2. 2MicroRNAs as Cancer Players: Potential Clinical and Biological Effects2007 · 62 citations
  3. 3Micro-RNA in Disease and Gene Therapy2011 · 56 citations
  4. 4MicroRNAs as Cancer Biomarkers: Unveiling Diagnostic and Prognostic Potential2025
  5. 5microRNA involvement in human cancer2025 · 2 citations